Treatment of Disorders of Tone and Other Considerations in Pediatric Movement Disorders

被引:5
作者
Deputy, Stephen R. [1 ]
Tilton, Ann H. [1 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr New Orleans, Div Child Neurol, Dept Neurol,Childrens Hosp, 200 Henry Clay Ave, New Orleans, LA 70118 USA
关键词
Pediatric movement disorders; Sydenham chorea; Glucose transporter deficiency; NBIA; Cerebral palsy; Treatment; Pediatrics; Childhood; TOXIN TYPE-A; DEEP BRAIN-STIMULATION; INTRATHECAL BACLOFEN INFUSION; GROSS MOTOR FUNCTION; CEREBRAL-PALSY; SECONDARY DYSTONIA; DANTROLENE SODIUM; ORAL BACLOFEN; DOUBLE-BLIND; CHILDREN;
D O I
10.1007/s13311-020-00984-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pediatric movement disorders (PMDs) consist of a heterogeneous group of signs and symptoms caused by numerous neurological diseases. Different neurological disorders in children also share overlapping movement disorders making a diagnosis of the underlying cause of the movement disorder challenging. The similarity of the symptoms across multiple disease types suggests that there may be a final common motor pathway causing the overlapping movement disorders. There are numerous disorders in children associated with disturbances in tone and involuntary movements. This chapter will focus primarily on those disorders that involve abnormalities of tone and other important considerations of pediatric movement disorders. This chapter will address rating scales and goals for treatment and will include a review of symptomatic treatment and, where possible, the treatment of the underlying disease processes. The chapter will review representative disorders, including an inborn error of metabolism, an autoimmune disorder, and a group of neurodegenerative disorders. These examples demonstrate how the disorder's underlying pathophysiology results in a specific approach to the underlying disease and the associated conditions of tone and involuntary movements. Finally, the multiple treatment options for cerebral palsy and considerations of cerebral palsy mimics will be discussed.
引用
收藏
页码:1713 / 1723
页数:11
相关论文
共 73 条
[1]   CONTINUOUS INTRATHECAL BACLOFEN INFUSION FOR SPASTICITY OF CEREBRAL ORIGIN [J].
ALBRIGHT, AL ;
BARRON, WB ;
FASICK, MP ;
POLINKO, P ;
JANOSKY, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (20) :2475-2477
[2]   Intrathecal baclofen for generalized dystonia [J].
Albright, AL ;
Barry, MJ ;
Shafron, DH ;
Ferson, SS .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2001, 43 (10) :652-657
[3]   Practice parameter: Diagnostic assessment of the child with cerebral palsy - Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society [J].
Ashwal, S ;
Russman, BS ;
Blasco, PA ;
Miller, G ;
Sandler, A ;
Shevell, M ;
Stevenson, R .
NEUROLOGY, 2004, 62 (06) :851-863
[4]   Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial [J].
Barwood, S ;
Baillieu, C ;
Boyd, R ;
Brereton, K ;
Low, J ;
Nattrass, G ;
Graham, HK .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2000, 42 (02) :116-121
[5]   Neurodegeneration with Brain Iron Accumulation [J].
Batla, Amit ;
Gaddipati, Chandana .
ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2019, 22 (03) :267-276
[6]   Movement Disorder-Childhood Rating Scale: Reliability and Validity [J].
Battini, Roberta ;
Sgandurra, Giuseppina ;
Petacchi, Elisa ;
Guzzetta, Andrea ;
Di Pietro, Roberta ;
Giannini, Maria T. ;
Leuzzi, Vincenzo ;
Mercuri, Eugenio ;
Cioni, Giovanni .
PEDIATRIC NEUROLOGY, 2008, 39 (04) :259-265
[7]   Proposed definition and classification of cerebral palsy, April 2005 - Introduction [J].
Bax, M ;
Goldstein, M ;
Rosenbaum, P ;
Leviton, A ;
Paneth, N .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2005, 47 (08) :571-576
[8]   Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments [J].
Billnitzer, Andrew ;
Jankovic, Joseph .
NEUROTHERAPEUTICS, 2020, 17 (04) :1681-1693
[9]  
BLAIR E, 1985, DEV MED CHILD NEUROL, V27, P615
[10]   Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation [J].
Bledsoe, Ian O. ;
Viser, Aaron C. ;
San Luciano, Marta .
NEUROTHERAPEUTICS, 2020, 17 (04) :1622-1644